4//SEC Filing
Williams Donald Allen 4
Accession 0001493152-26-003078
CIK 0001357459other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:05 PM ET
Size
5.4 KB
Accession
0001493152-26-003078
Research Summary
AI-generated summary of this filing
Palisade Bio (PALI) Director Donald Allen Buys 5,000 Shares
What Happened
Donald Allen, a director of Palisade Bio (PALI), made an open-market purchase of 5,000 shares on 2026-01-16 at $1.67 per share, for a total of $8,356. This was a purchase (Form 4 code P), which investors often view as a more informative signal than routine insider sales.
Key Details
- Transaction date: 2026-01-16
- Price: $1.67 per share; Shares purchased: 5,000; Total value: $8,356
- Transaction type: Open-market purchase (Code P)
- Form 4 filing date: 2026-01-21 — filed within the standard two business-day window (timely)
- Shares owned after the transaction: Not specified in the provided filing excerpt
- Footnotes/plans: No 10b5-1 plan, tax-withholding, or other special footnotes were reported in the provided excerpt
Context
- Insider purchases can indicate confidence but are not proof of future stock performance.
- The purchase size is modest (~$8.4k), so while it shows insider buying, it’s relatively small compared with larger insider or institutional transactions.
Insider Transaction Report
Form 4
Williams Donald Allen
Director
Transactions
- Purchase
Common Stock
2026-01-16$1.67/sh+5,000$8,356→ 10,728 total
Holdings
- 3,000(indirect: By Reporting Person's Defined Benefit Plan)
Common Stock
Signature
/s/ Ryker Willie, Attorney-in-Fact|2026-01-21
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001620013
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:05 PM ET
- Size
- 5.4 KB